WARD Covid-19

WARD Covid-19

Principal Investigator

Katja Kjær Grønbæk, MD, PhD student

Study design
Prospective controlled cohort; non-randomised interventional study
Sample size
97 participants
Study sites

Bispebjerg Hospital and Rigshospitalet

Inclusion criteria
  • Adult patients (≥18 years).
  • Inclusion possible within 72 hours of admission, OR within 48 hours of discharge from an ICU to a medical ward
  • At least one expected overnight stay.
  • Patient admitted with confirmed COVID-19 infection
Study procedures

The study evaluated continuous wireless monitoring with staff alerts against routine Early Warning Score monitoring. Remote access to readings allowed staff to view vital signs outside the patient room.

Outcome

Primary outcome: cumulative duration of severely abnormal vital signs. The registry reports 97 participants and early termination for lack of funding.

Trial registration
NCT04724681

–  Read more